LPL Financial
TNGX icon

LPL Financial’s Tango Therapeutics TNGX Stock Holding History

LPL Financial’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$341K Sell
13,673
-4,737
-26% -$123K ﹤0.01% 5427
2026
Q2 		$575K Buy
+18,410
New +$455K ﹤0.01% 4904
2026
Q1 		– Sell
-12,000
Closed -$106K – 6160
2025
Q4 		$106K Buy
+12,000
New +$103K ﹤0.01% 5581

Other funds holding TNGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

LPL Financial's TNGX Position: Q3 2026 in Review

LPL Financial reduced its Tango Therapeutics (TNGX) stake by 26% in Q3 2026, selling an estimated $123K and leaving 13,673 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #5427.

LPL Financial first reported a position in TNGX in Q4 2025 and has held it in 3 quarters since. The position peaked at $575K in Q2 2026. 161 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • LPL Financial held 13,673 shares of Tango Therapeutics worth $341K as of Q3 2026.
  • LPL Financial sold 4,737 Tango Therapeutics shares in Q3 2026, an estimated $123K.
  • Tango Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5427 holding.
  • LPL Financial first reported a position in Tango Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • LPL Financial's Tango Therapeutics position peaked at $575K in Q2 2026.
  • 161 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.